跳转到内容

FV-100

维基百科,自由的百科全书
FV-100
IUPAC名
3-(2-Deoxy-β-D-erythro-pentofuranosyl)-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
系统名
3-[(2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-2(3H)-one
别名 Cf1743
识别
CAS号 956483-02-6  checkY
PubChem 493485
ChemSpider 431897
SMILES
 
  • CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)CO)O
性质
化学式 C22H26N2O5
摩尔质量 398.45 g·mol−1
若非注明,所有数据均出自标准状态(25 ℃,100 kPa)下。

FV-100(也称为Cf1743)是一种含氮有机化合物,分子式C
22
H
26
N
2
O
5
,属于核苷酸类似物[1],可作为抗病毒药物[2],用于治疗带状疱疹[3]

参考文献

[编辑]
  1. ^ Inhibitex Completes Phase I Clinical Trials For FV-100 And Selects Lead HCV Compounds For Advanced Preclinical Studies, 2009 
  2. ^ McGuigan, Christopher; Balzarini, Jan. FV100 as a new approach for the possible treatment of varicella-zoster virus infection. Journal of Antimicrobial Chemotherapy. 2009, 64 (4): 671–673. PMID 19679595. doi:10.1093/jac/dkp294可免费查阅. 
  3. ^ Tyring, SK; Lee, P; Hill GT, Jr; Silverfield, JC; Moore, AY; Matkovits, T; Sullivan-Bolyai, J. FV-100 versus valacyclovir for the prevention of post-herpetic neuralgia and the treatment of acute herpes zoster-associated pain: A randomized-controlled trial.. Journal of medical virology. 2017-07, 89 (7): 1255–1264. PMID 27943311. doi:10.1002/jmv.24750. 

外部链接

[编辑]